NOD2 and colorectal carcinoma: In a related context, individuals with NOD2 polymorphisms (3020insC and R702W) appear to have an increased susceptibility to CRC [62], lung, laryngeal, urogenital, pancreatic, melanoma, gastric cancers, non-Hodgkin’s and MALT lymphomas [63].